ERCC2 and colorectal carcinoma: The Taiwanese CRC patients with ERCC2 2251AC and ERCC2 2251CC genotypes have a risk of recurrence 3.294 times greater than that of those with other genotypes (P = 0.01; 95% CI, 1.272–8.532).